A
new version of EudroVigillance, the European information system of suspected
adverse reactions to medicines that are authorized or being studied in clinical
trials in the European Economic Area (EEA) is available.
The
new system makes it easier for marketing authorization holders and sponsors of
clinical trials to report suspected adverse reactions and allows for better
analysis of this information for the benefit of patient safety in Europe.
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources